Stay updated with breaking news from Wheeze Detection. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- TytoCare, a virtual care company enabling accessible, high-quality primary care from home, today announced that it received FDA clearance for...
Virtual care company TytoCare has received FDA clearance for its wheeze detection algorithm, allowing the company to begin commercializing the product in the U.S. The new algorithm is an expansion of Tyto Insights, the company's AI-powered diagnosis support software.
TytoCare, a virtual care company enabling, primary care from home received FDA clearance for its Tyto Insights for Wheeze Detection
Also: FDA approves TytoCare's wheeze detection device, Gates Foundation funds breathalyzer that can detect infectious disease, and Google announces radiotherapy AI plan with Mayo Clinic.
Tyto Insights for Wheeze Detection analyzes lung sounds for possible wheezing in adults and children 2 and older.